Can nitroglycerin capsule pellets be placed sublingually if a specific sublingual formulation is not available?

Do Not Use Nitroglycerin Capsule Pellets Sublingually

Nitroglycerin capsule pellets should not be placed sublingually as a substitute for proper sublingual formulations. The FDA-approved sublingual nitroglycerin formulations are specifically designed tablets or sprays—not capsules—and the drug label explicitly states that "nitroglycerin sublingual tablets are intended for sublingual or buccal administration and should not be swallowed" 1. This guidance applies specifically to approved sublingual tablets, not to repurposing oral capsule formulations.

Why Capsule Pellets Are Not Appropriate

The pharmacokinetics of sublingual nitroglycerin absorption are highly specific to the formulation:

• Sublingual tablets are designed to dissolve rapidly under the tongue, achieving peak plasma concentrations at a mean of 5.3 minutes (though this can vary from immediate to 10 minutes) with a bioavailability of approximately 36% 2
• Oral capsules contain pellets designed for gastrointestinal absorption after swallowing, not buccal/sublingual absorption
• The pellet matrix and coating are formulated for stomach acid dissolution, not the pH and enzymatic environment of the oral mucosa

Research comparing nitroglycerin formulations found that soft gelatin capsules (0.8 mg) were designed for oral administration and evaluated against sublingual tablets using different absorption pathways 3. There is no evidence supporting the sublingual use of oral capsule pellets.

Approved Alternatives When Sublingual Tablets Are Unavailable

If sublingual nitroglycerin tablets are not available, the evidence-based alternatives include:

First-Line Alternative: Nitroglycerin Spray

• Nitroglycerin spray (0.4 mg) is FDA-approved for sublingual/buccal use 4
• Provides similar onset and duration to sublingual tablets 5
• Offers superior shelf-life stability (3 years vs. 12 weeks for opened tablet bottles) 6
• Guidelines specifically recommend "nitroglycerine spray of 400 μg (2 puffs) every 5–10 min" as an alternative to sublingual tablets 7

Second-Line Alternative: Buccal Isosorbide Dinitrate

• Buccal isosorbide dinitrate (1 or 3 mg) is mentioned in ESC guidelines as an alternative for acute heart failure 7
• Provides relatively rapid onset with 3-4 times daily dosing capability

When Acute Treatment Is Needed: Intravenous Nitroglycerin

For hospitalized patients with ongoing ischemia or acute heart failure:

• Initiate IV nitroglycerin at 10-20 μg/min, titrating by 5-10 μg/min every 3-5 minutes 7, 4, 5
• Provides precise minute-to-minute control
• Avoid if systolic BP <90 mmHg or >30 mmHg below baseline 5, 8

Critical Safety Considerations

Contraindications apply to all nitroglycerin formulations 1:

• Recent phosphodiesterase-5 inhibitor use (sildenafil within 24h, tadalafil within 48h)
• Systolic blood pressure <90 mmHg
• Suspected right ventricular infarction (especially with inferior MI)
• Concurrent use with soluble guanylate cyclase stimulators (riociguat)

Common Pitfalls to Avoid

1. Do not assume oral formulations work sublingually: The absorption characteristics, onset time, and bioavailability differ fundamentally between routes
2. Do not open capsules for sublingual use: This is off-label, unsupported by evidence, and potentially dangerous due to unpredictable absorption
3. Ensure proper storage: Even approved sublingual tablets lose potency rapidly once the bottle is opened—they must be kept in the original glass container, tightly capped 1

The Bottom Line

Use only FDA-approved sublingual/buccal formulations (tablets or spray). If these are unavailable in an acute setting, transition to IV nitroglycerin for hospitalized patients or prescribe the spray formulation for outpatient use. There is no role for improvising with oral capsule pellets placed sublingually.